New York state based biotech company, Regeneron, is working on an antibody therapy to treat, and possibly prevent, Covid-19.
Credit: Regeneron
Stories this photo appears in:
Trump has ties to drug maker Regeneron -- and now its stock is surging
President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. Now the drugmaker's stock is up sharply -- and questions are swirling about the president's ties to Regeneron's billionaire CEO.
